Literature DB >> 10091063

Ovarian markers of implantation potential in assisted reproduction.

L Gregory1.   

Abstract

In-vitro fertilization provides evidence for the heterogeneity of human embryos; data from the UK indicating that approximately 90% of embryos selected for transfer fail to implant. The need to identify factors that promote implantation or markers of implantation is self-evident. There is an increasing awareness that the heterogeneity of follicles may have a significant impact on oocyte competence and embryo viability and that factors which contribute to the heterogeneity of follicles may provide markers of implantation in assisted conception. The markers of implantation described include the expression of 11 beta-hydroxysteroid dehydrogenase by granulosa cells in vitro; adhesion and proliferation of cumulus cells in vitro; steroidogenic activity of cumulus in vitro and perifollicular vascularity and vascular endothelial growth factors bound to granulosa and cumulus cells. These factors may provide clinically useful markers of implantation potential.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10091063     DOI: 10.1093/humrep/13.suppl_4.117

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  8 in total

1.  Power Doppler ultrasound assessment of follicular vascularity in the early follicular phase and its relationship with outcome of in vitro fertilization.

Authors:  S M Shrestha; M F Costello; P Sjoblom; G McNally; M Bennett; S J Steigrad; G J Hughes
Journal:  J Assist Reprod Genet       Date:  2006-04-22       Impact factor: 3.412

2.  Power doppler ultrasound assessment of the relationship between age and ovarian perifollicular blood flow in women undergoing in vitro fertilization treatment.

Authors:  Michael F Costello; Sanu M Shrestha; Peter Sjoblom; Glen McNally; Michael J Bennett; Stephen J Steigrad; Graeme J Hughes
Journal:  J Assist Reprod Genet       Date:  2006-10-11       Impact factor: 3.412

3.  Follicular development and hormonal levels following highly purified or recombinant follicle-stimulating hormone administration in ovulatory women undergoing ovarian stimulation after pituitary suppression for in vitro fertilization: implications for implantation potential.

Authors:  J Balasch; F Fábregues; M Creus; J Peñarrubia; E Vidal; F Carmona; B Puerto; J A Vanrell
Journal:  J Assist Reprod Genet       Date:  2000-01       Impact factor: 3.412

4.  Administration of beta2-adrenergic agonists during the peri-implantation period does not improve implantation or pregnancy rates in intracytoplasmic sperm injection (ICSI) cycles.

Authors:  Osni L Pinheiro; Mario Cavagna; Ricardo L R Baruffi; Ana L Mauri; Claudia Petersen; José G Franco
Journal:  J Assist Reprod Genet       Date:  2003-12       Impact factor: 3.412

5.  Transcriptome dynamics and molecular cross-talk between bovine oocyte and its companion cumulus cells.

Authors:  A Regassa; F Rings; M Hoelker; U Cinar; E Tholen; C Looft; K Schellander; D Tesfaye
Journal:  BMC Genomics       Date:  2011-01-24       Impact factor: 3.969

6.  Molecular analysis of the cumulus matrix: insights from mice with O-glycan-deficient oocytes.

Authors:  Panayiota Ploutarchou; Pedro Melo; Anthony J Day; Caroline M Milner; Suzannah A Williams
Journal:  Reproduction       Date:  2015-05       Impact factor: 3.906

7.  Does Perifollicular Vascularity on the Day of Oocyte Retrieval Affect Pregnancy Outcome in an In Vitro Fertilization Cycle?

Authors:  Nikita Naredi; Santosh Kumar Singh; Rajesh Sharma
Journal:  J Hum Reprod Sci       Date:  2017 Oct-Dec

8.  Optimal Ovulation Trigger-Oocyte Pickup Interval in Progestin-Primed Ovarian Stimulation Protocol: A Retrospective Study Using Propensity Score Matching.

Authors:  Xi Shen; Hui Long; Wenya Guo; Hongyuan Gao; Renfei Cai; Wei Jin; Zhiguang Yan; Shaozhen Zhang; Yun Wang; Qifeng Lyu; Li Wang; Yanping Kuang
Journal:  Front Endocrinol (Lausanne)       Date:  2019-10-15       Impact factor: 5.555

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.